Home | Business News | Browse by Publication | J | Japan Weekly Monitor

Takeda-Abbott venture faces fine for drug price-gouging: paper.

Publication: Japan Weekly Monitor
Publication Date: 04-JUN-01
Format: Online
Delivery: Immediate Online Access

Article Excerpt
NEW YORK, May 28 Kyodo

A joint venture of Abbott Laboratories Inc. and Japan's Takeda Chemical Industries Ltd. is preparing to pay a fine of some $840 million to settle a U.S. Justice Department case that it inflated the price of its top-selling prostate cancer drug, the Boston Globe...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Japan Weekly Monitor
Dollar dips as M&A rumor spurs euro sales, yen purchases., June 04, 2001
IMF chief urges Japan to strengthen financial system., June 04, 2001
Fresh warrants served on 3 in seizure of 143 kg of drugs., June 04, 2001
EMBARGOED: Nakauchi to give up representative right of Recruit., June 04, 2001
Nakauchi to give up representative right of Recruit., June 04, 2001

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.